跳至主要内容
临床试验/NCT02463409
NCT02463409已完成2 期

Effects of Theophylline on cAMP Signaling in Children With Pseudohypoparathyroidism Type 1a

Vanderbilt University Medical Center1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2015年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
6
试验地点
1
主要终点
Change in Urine cAMP

研究概览

简要总结

This study will test an investigational drug, theophylline, in children with pseudohypoparathyroidism type 1a (PHP1a). This study involves a 3 day visit to the Vanderbilt Clinical Research Center.

详细描述

Study measures will be done at baseline and during a 24h infusion of IV theophylline. Theophylline levels will be drawn to ensure therapeutic dosing and to monitor for toxicity. Measures include laboratory values, response to PTH infusion and resting energy expenditure.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
10 Years 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Age 10 to 21 years old
  • English proficiency
  • Clinical and genetic diagnosis of PHP1a

排除标准

  • Use of a PDE inhibitor in the past 30 days
  • History of a seizure disorder unrelated to hypocalcemia
  • History of a cardiac arrhythmia (not including bradycardia)
  • History of hepatic insufficiency
  • AST or ALT >2x upper limit of normal
  • Total bilirubin >1.5 x upper limit of normal (unless patient has a diagnosis of Gilbert's syndrome and no other causes leading to hyperbilirubinemia are identified)
  • Congestive heart failure
  • Cigarette use in the past 30 days
  • Alcohol use within the past 24 hours
  • Current pregnancy
  • Untreated hypothyroidism (defined as free T4 level < 0.6 ng/dL or TSH >10 mcU/mL)
  • Active peptic ulcer disease
  • Fever >101 degrees in the past 24 hours
  • Current use of medications known to effect theophylline levels (listed below)
  • Severe sleep apnea requiring BiPAP
  • Drugs with clinically significant drug interactions with theophylline:
  • Allopurinol
  • Cimetidine
  • Ciprofloxacin
  • Clarithromycin
  • Ephedrine
  • Erythromycin
  • Flurazepam
  • Fluvoxamine
  • Lorazepam
  • Methotrexate
  • Midazolam
  • Pentoxifylline
  • Propranolol
  • Sulfinpyrazone
  • Thiabendazole
  • Ticlopidine
  • Troleandomycin
  • Verapamil

研究组 & 干预措施

Theophylline

Experimental

Patients will receive a 24 hour continuous infusion of intravenous theophylline.

干预措施: Theophylline (Drug)

结局指标

主要结局

Change in Urine cAMP

时间窗: 1 day

Change in urine cAMP (after parathyroid hormone stimulation) before and during treatment with theophylline

次要结局

  • Change in Apnea Hypopnea Index (AHI)(1 day)
  • Change in Resting Energy Expenditure (REE)(1 day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ashley Shoemaker

Assistant Professor

Vanderbilt University Medical Center

研究点 (1)

Loading locations...

相似试验